Table of Contents
<< Previous Issue | Sep 2008 (Vol: 2008, Issue: 100) | Next Issue >> |
- Section: Business Commentaries
-
Will Lehman’s Collapse Affect the Pharmaceutical Industry?
- Section: Joint Venture
-
Teva and Kowa to Create Leading Generics Business in Japan
- Section: Licensing
-
Medivation and Pfizer to Partner on Alzheimer’s Drug
-
Ablynx’s Nanobodies® Take in Another Big Pharma
-
Cellzome’s Billion Dollar Deal with GSK
-
CV Therapeutics Aims High Through its Agreement with Menarini
-
Astellas Receives Worldwide Commercial Rights to Major Preclinical Programme
-
Merck Signs Osteoporosis Deal with Japan Tobacco
- Section: Mergers & Acquisitions
-
Novacea Rescued by Transcept
-
Shionogi Keeps Up with Latest Japanese Pharma Trend
-
Bayer’s Foray into Biotech
-
Protherics Agrees to Takeover by BTG
-
Sanofi-aventis Gains Zentiva With Sweeter Offer
- Section: Research & Development
-
Merck Heads Back to India for More Anti-Infective Programmes